Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (7972)	12/7/1998 8:43:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Opal, as you know I have always had respect for your thinking. Do you have anything more concrete? Do you really think the McKensie poll had anything to do with proposal of move of domicile to Bermuda? And if so what? I got the impression that the move was the opinion of the Lehman male siblings not some devious plot by Xoma. Don't you think it would of been odd to pay an entity of their stature around a half a million dollars and then not take their advice? I see so many other ethical companies with parts of their companies in Bermuda. BTW, I am thrilled to be a shareholder of a company that does everything it can to avoid lawsuits in this day and age.

To: opalapril who wrote (7972)	12/7/1998 9:41:00 PM
From: LLCF	Respond to of 17367

Frankly I see NO reason to pay the U.S. Govt anything if all the revenues are coming out of Europe in the beginning right? They get enough of the pie as it is... cash is crucial in their fight to survive! DAK

To: opalapril who wrote (7972)	12/7/1998 11:22:00 PM
From: aknahow	Respond to of 17367

Sorry to hear you voted no but everyone is free to do what they want and you and I both have. The original poll was probably to get data on non registered holders to see if any held 10%. If any had held 10% of the stock XOMA would have had to explain to them some potential tax liability, but as the prospectus points out none did. In any event, if you hold other biotech stocks with products in late trials and potential earnings from overseas, I suggest you think about the issue again. You only have two feet and you might not want to shoot yourself in the other one. <g> This is an idea that makes a lot of sense in general. I am sure we will see at least 5 biotechs do the same in 1999. I have maintained my trust in XOMA. Look at the XOMA site. I have found much more disclosure there than on any other biotech site or any other non biotech company that I follow. This does not mean I think XOMA makes no errors.